Cost and Visit Duration of Same-Day Access at an Academic Ophthalmology Department vs Emergency Department

Factors Affecting Visits to the Emergency Department for Urgent and Nonurgent Ocular Conditions

Ophthalmology.

Stagg BC, Shah MM, Talwar N, Padovani-Claudio DA, Woodward MA, Stein JD

doi: 10.1016/j.ophtha.2016.12.039.

COMMENTED

Retinal Diseases

Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease

JAMA Ophthalmol.

Johnson S, Buessing M, O'Connell T, Pitluck S, Ciulla TA

doi: 10.1001/

Retinal Diseases

Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

JAMA Ophthalmol.

Hutton DW, Stein JD, Glassman AR, Bressler NM, Jampol LM, Sun JK, DRCR Retina Network.

doi: 10.1001/jamaophthalmol.2019.4284.

Macular Diseases

Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial

JAMA Ophthalmol.

Ramakrishnan MS, Yu Y, VanderBeek BL

doi: 10.1001/jamaophthalmol.2019.4577.

Further Publications

Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context

BMC Ophthalmol.

Schmid MK, Reich O, Blozik E, Faes L, Bodmer NS, Locher S, Thiel MA, Rapold R, Kuhn M, Bachmann LM

doi: 10.1186/s12886-018-0731-4.

Utilization of Ophthalmologist Consultation for Emergency Care at a University Hospital

JAMA Ophthalmol.

Wang SY, Hamid MS, Musch DC, Woodward MA

doi: 10.1001/jamaophthalmol.

COMMENTED

Retinal Diseases

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

JAMA Ophthalmol.

Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW, Diabetic Retinopathy Clinical Research Network

doi: 10.1001/jamaophthalmol.

COMMENTED

Macular Diseases

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial

JAMA.

Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK, DRCR Retina Network.

doi: 10.1001/jama.2019.5790.

Retinal Diseases

Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network

JAMA Ophthalmol.

Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S

doi: 10.1001/

Related content

Factors Affecting Visits to the Emergency Department for Urgent and Nonurgent Ocular Conditions

Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease

Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial

Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context

Utilization of Ophthalmologist Consultation for Emergency Care at a University Hospital

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial

Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network